MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • 2018 International Congress

    Alzheimer’s Disease Genetic Risk Variants Predict Cognitive Decline in Parkinson’s Disease

    T. Tropea, K. Maddy, J. Rick, J. Trojanowkski, D. Weintraub, A. Chen-Plotkin (Philadelphia, PA, USA)

    Objective: To evaluate the effect of genetic variants implicated in Alzheimer’s disease (AD) risk on cognitive decline in Parkinson’s disease (PD). Background: People with PD…
  • 2018 International Congress

    Dielectric Properties of Blood Plasma Predict Cognitive Impairment in an Amyloid-Beta-Induced Rat Model of Alzheimer’s Dementia

    E. Dalle, A. Lonappan, M. Mabandla, W. Daniels (Durban, South Africa)

    Objective: This study presents a novel method of predicting the behavioral pattern in male Sprague-Dawley rats with impaired learning and memory, based on the measurement…
  • 2018 International Congress

    Evaluation of the Loneliness among the Caregivers of Parkinson Disease Dementia

    M. Gultekin, A. Ekinci (Kayseri, Turkey)

    Objective: This study examined loneliness among caregivers of individuals with Parkinson’s disease dementia(PDD). Background: Caregivers of people with PDD have loneliness and depression. Methods: The…
  • 2017 International Congress

    Cause-Specific Hazard of Motor and Nonmotor Long Term Complications of Idiopathic Parkinson’s Disease in a Hospital-based Outpatient Clinic Incident Cohort of 1333 Patients

    S. Prange, C. Laurencin, t. danaila, m.-b. delphine, S. Thobois (bron, France)

    Objective: To compare the relative incidence rates, at identical disease duration, of motor and nonmotor clinical milestones in the long-term disease course of Parkinson’s disease…
  • 2017 International Congress

    Tau predicts cognitive impairment in a prospective longitudinal CSF study in Parkinson’s Disease

    S. Lerche, I. Wurster, O. Hanson, B. Roeben, C. Schulte, T. Gasser, H. Zetterberg, D. Berg, W. Maetzler, K. Brockmann (Tuebingen, Germany)

    Objective: We hypothesize that CSF profiles of Aβ and Tau (total and phosphorylated) are associated with clinical subtypes and disease progression. Background: Parkinson’s disease (PD)…
  • 2017 International Congress

    Cognitive impairment in early onset and familial Parkinson’s disease.

    M. Tan, J. Bras, J. Hong, C. Brugaletta, T. Samakomva, K. Hoffmann, S. Lubbe, D. Grosset, N. Wood, A. Schapira, J. Hardy, H. Houlden, H. Morris (London, United Kingdom)

    Objective: The Parkinson’s Families Project (PFP) is a large-scale cohort of early onset (symptom onset <45) and familial Parkinson’s disease (PD) patients. One aim of…
  • 2017 International Congress

    What impacts relationship satisfaction in Parkinsonian dementias?

    S. Vatter, K. McDonald, S. McCormick, I. Leroi (Manchester, United Kingdom)

    Objective: To explore which aspects of well-being impact on marital relationship satisfaction among people with Parkinsonian dementias and their spouses. Background: Dyadic relationships in Parkinson’s disease…
  • 2017 International Congress

    Development and validation of an alternative version of the Parkinson’s Disease-Cognitive Rating Scale

    R. Fernandez-Bobadilla, S. Martinez-Horta, J. Marin-Lahoz, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To develop and validate an alternative form of the PD-CRS (PD-CRS/AF) with the objective of providing a reliable and fully equivalent method of reassessment…
  • 2017 International Congress

    SNCA multiplication consortium: Clinicogenetic analysis of SNCA multiplication probands and families.

    A. Book, M. Farrer, T. Candido, I. Guella, D. Evans, E. Gustavsson (Vancouver, BC, Canada)

    Objective: Clinicogenetic analysis of 57 affected probands with SNCA multiplication, 3 unaffected carriers, and their 60 families. To use informative pedigrees to identify penetrance modifiers…
  • 2017 International Congress

    Validation of the performance based Erlangen Test of Activities of Daily Living in PD

    I. Liepelt-Scarfone, L. Liebig, P. Sulzer, D. Berg (Tübingen, Germany)

    Objective: The Erlangen Test of Activities of Daily Living (E-ADL) is a performance-based test to assess the activity of daily living (ADL) dysfunction associated with…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley